吸收性局部止血材料的全球市场 - 市场规模(各市场区隔)，占有率，法规，偿付，干预，预测(～2036年)

本报告提供全球吸收性局部止血材料市场相关调查分析，提供各地区市场规模，主要趋势，创新的产品与技术，竞争情形等资讯。

市场模型的主要组成如下：

目前可用的可吸收局部止血剂和不断发展的竞争格局

• 主要产业趋势分析
• 可吸收局部止血剂市场各细分市场的年收入及市场预测（2015-2036 年）
• 单位数量、平均销售价格和市场价值的市场层面数据

全球、区域和国家层面的市场洞察

• 按地区和全球趋势细分的定性市场讯息，并提供每个国家/地区的市场洞察
• 可吸收局部止血剂市场的 SWOT 分析
• 可吸收局部止血剂市场竞争态势分析及趋势

透过获得真正的整体视角（包括医疗保健系统概述）来了解您的市场。此外，市场进入部分提供有关报销政策和监管环境的信息，从而可以更深入地了解市场动态。

• 各国医疗保健体系概述
• 各国的报销政策
• 各国医疗科技监理状况

对象企业

• Ethicon Inc
• CR Bard Inc
• Pfizer Inc
• B. Braun Melsungen AG
• Teleflex Inc
• Medtronic Plc
• Gelita Medical GmbH
• Meril Life Sciences Pvt Ltd
• 其他

Topical Absorbable Hemostats Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Wound Care Management therapeutic area.

Topical absorbable hemostats are agents used to promote and accelerate hemostasis to control bleeding in cases where application of pressure, ligature, and other conventional methods are ineffective. Topical absorbable hemostats are inserted to remove excess blood, thereby preventing further bleeding and clearing up the operating site for the surgeon.

Topical absorbable hemostats, or passive hemostats, include collagen, gelatin, polysaccharide, oxidized regenerated cellulose, and combination hemostats. These agents, applied as sponges, foams, or pads, vary in properties based on the surgical specialty, patient needs, procedure requirements, type of bleeding, and the agent's mechanism of action.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Topical Absorbable Hemostats and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Topical Absorbable Hemostats market revenue by segment and market outlooks from 2015-2036.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Topical Absorbable Hemostats market.
• Competitive dynamics insights and trends provided for Topical Absorbable Hemostats market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Ethicon Inc, CR Bard Inc, Pfizer Inc, B. Braun Melsungen AG, Teleflex Inc, Medtronic Plc, Gelita Medical GmbH, Meril Life Sciences Pvt Ltd and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Topical Absorbable Hemostats marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Topical Absorbable Hemostats market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Topical Absorbable Hemostats market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Topical Absorbable Hemostats market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.